Health & Family Life

FDA Clears Ultrapotent Opioid Despite Outsiders’ Warning

Carol Duff, MSN, BA, RN
{p}Carol graduated from Riverside White Cross School of Nursing in Columbus, Ohio and received her diploma as a registered nurse. She attended Bowling Green State University where she received a Bachelor of Arts Degree in History and Literature. She attended the University of Toledo, College of Nursing, and received a Master's of Nursing Science Degree as an Educator.{/p}{p}She has traveled extensively, is a photographer, and writes on medical issues. Carol has three children RJ, Katherine, and Stephen - two daughters-in-law; Suzy and Katie - two granddaughters; Isabella Marianna and Zoe Olivia - and one grandson, Alexander Paul. She also shares her life with husband Gordon Duff, many cats, two rescue pups, and two guinea pigs.{/p}{p}Carol's Archives 2009-2013{/p}

2 Replies to “FDA Clears Ultrapotent Opioid Despite Outsiders’ Warning

  1. Could the plan be to reduce the number of heroin addicts by having them all overdose? Wouldn’t that reduce profits? Maybe this is to drive up the sale of Naloxone. Pretty crafty these Big Pharma folks.

Comments are closed.